secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001213900-25-005263
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed granted first PCT patent in Mexico for novel cannabinoid analog compounds
-------------------------------------------------------------------------------

- Patent No. 417531 issued in Mexico; covers novel small molecule compounds and methods of preparation.
- Therapeutic applications include pain, glaucoma, inflammatory disease, anxiety, and neurological conditions like Parkinson's and Alzheimer's.
- Patent holds 20-year term; international application pending in U.S., Europe, Japan, and others.
- InMed now has 14 patent families covering compositions, formulations, manufacturing, and methods of use.
- Compounds are drug candidates for Alzheimer's disease and dry age-related macular degeneration programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025005263/0001213900-25-005263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025005263/ea0228337-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-005263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer